Medical tech firm Becton Dickinson to buy C.R. Bard for $24B

FRANKLIN LAKES, N.J. (AP) - Medical technology firm Becton, Dickinson and Co. says it has reached an agreement to buy competitor C.R. Bard Inc. in a cash-and-stock deal worth $24 billion.

The deal announced Sunday was approved by both companies' boards but still needs regulatory and Bard shareholder approvals. It's ...